Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Evaluation of Paclitaxel and Cisplatin Combinations in TNBC: A Strategy to Enhance Efficacy and Minimize Exposure
Saved in:
| Published in: | International Journal of Life Sciences and Biotechnology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Evaluation of Paclitaxel and Cisplatin Combinations in TNBC: A Strategy to Enhance Efficacy and Minimize Exposure
- Development of niosomal nanoparticles loaded with cisplatin and vorinostat combination for cancer therapy
- Retracted: Efficacy Analysis of Comprehensive Nursing in the Care of Ovarian Carcinoma Treated with Paclitaxel Combined with Nedaplatin
- Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells
- Optimization of agarose-gelatin double embedding to minimize sectioning artifacts in multicellular spheroids
- Multi‐Omics Combined With Mitochondrial Feeding Assays Reveal a Novel Energy Metabolism Strategy for Floral Thermogenesis in Magnolia Driven by Synergistic Supply of Multiple Substrates
- High-resolution molecular typing of vancomycin-resistant Enterococcus faecium from Romania and Bavaria: combining enhanced DNA microarray and next generation sequencing